Some of the world’s biggest health challenges do not lend themselves to conventional investment
“Dementia is a massive, massive swing for the fences, because it’s so tough, but it shouldn’t be so tough that no one ever tries,” says Kate Bingham, former head of the UK’s Vaccine Taskforce and managing partner at SV Health Investors, which advises the DDF.
“There are effectively no products out there benefiting patients today,” Barker says. “And, correspondingly, if there is [any] success at all across the portfolio, the likely financial upside could be very significant.”